The manufacturing process is complex, technically demanding and takes place under sterile conditions. The plant employs just over 80 people. Global demand for the analogue of the pituitary stimulant LHRH has increased and its testing is claimed to be highly complex. Other pharmaceuticals will also be tested in the new laboratory building. Investment at the site is set to continue.
Production capacity is between half and two tonnes a year.
The drugs are not expected to go on the market until 2001, since they have yet to receive clearance from the drug safety authorities.